Carl Zeiss Meditec Revenue Climbs Steadily

Carl Zeiss Meditec AG saw its revenue climb to €630.8 million over the first nine months of its 2011-12 financial year, a year-over year increase of 13.6 percent.

The company anticipates further growth for the current financial year, expecting revenue between €830 and €860 million (about $1.03 billion and $1.06 billion), which corresponds to overall growth between 9 and 13 percent.

"In spite of an increasingly difficult situation in the global economy, we achieved a solid result, with double-digit revenue growth, and stick firmly to our revenue forecast for the year as a whole," said Ludwin Monz, president and CEO of Carl Zeiss Meditec AG.

All regions and strategic business units contributed to the growth, the company said. Persistently strong demand from the US and revenue contributions from Latin America grew the Americas region to 14.1 percent, the most in the nine-month period. The Asia-Pacific region grew by 13.7 percent. The Europe, Middle East and Africa region — with robust demand from Germany and Russia — generated 12.9 percent more revenue than in the same period of 2011.

Demand for surgical microscopes for neurosurgery boosted the Microsurgery business unit, which achieved growth of 21.6 percent. The Surgical Ophthalmology unit's revenue increased 13.3 percent from sales of intraocular lenses for minimally invasive cataract surgery as well as a sales acquisition in Spain. Growth of 6.1 percent in the Ophthalmic Systems strategic business unit was attributed to the demand for refractive lasers, which enable a new type of treatment for ametropia, or faulty refraction of light rays in the eye.

“We consider ourselves well equipped for the future with our diversified product portfolio, which ranges from ophthalmology, through microsurgery, to innovative applications in radiation therapy, the expansion of our solutions business, and our service range,” Monz said.

The company will adhere to its previously forecasted target of a 15 percent earnings before interest and taxes margin by 2015.

For more information, visit: www.meditec.zeiss.com